{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:12:04Z","timestamp":1778566324340,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T00:00:00Z","timestamp":1555891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12891-019-2527-y","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T14:02:35Z","timestamp":1555941755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data"],"prefix":"10.1186","volume":"20","author":[{"given":"Guochun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqi","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangpei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongbao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongyi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor","family":"Due\u00f1as","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Skljarevski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,22]]},"reference":[{"issue":"9","key":"2527_CR1","first-page":"646","volume":"81","author":"AD Woolf","year":"2003","unstructured":"Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81(9):646\u201356.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"2527_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2368","volume":"10","author":"QY Zeng","year":"2008","unstructured":"Zeng QY, Chen R, Darmawan J, Xiao ZY, Chen SB, Wigley R, et al. Rheumatic diseases in China. Arthritis Res Ther. 2008;10(1):1\u201311.","journal-title":"Arthritis Res Ther"},{"issue":"9859","key":"2527_CR3","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","volume":"380","author":"T Vos","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2163\u201396.","journal-title":"Lancet"},{"issue":"1","key":"2527_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.23176","volume":"58","author":"RC Lawrence","year":"2008","unstructured":"Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58(1):26\u201335.","journal-title":"Arthritis Rheum"},{"issue":"9783","key":"2527_CR5","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0140-6736(11)60243-2","volume":"377","author":"JW Bijlsma","year":"2011","unstructured":"Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377(9783):2115\u201326.","journal-title":"Lancet."},{"issue":"11","key":"2527_CR6","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/nrrheum.2013.138","volume":"9","author":"A-M Malfait","year":"2013","unstructured":"Malfait A-M, Schnitzer TJ. Towards a mechanism-based approach to pain management in osteoarthritis. Nat Rev Rheumatol. 2013;9(11):654\u201364.","journal-title":"Nat Rev Rheumatol"},{"issue":"mar31 2","key":"2527_CR7","doi-asserted-by":"publisher","first-page":"h1225","DOI":"10.1136\/bmj.h1225","volume":"350","author":"G. C. Machado","year":"2015","unstructured":"Machado GC, Maher CG, Ferreira PH, Pinheiro MB, Lin C-WC, Day RO, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ. 2015;350.","journal-title":"BMJ"},{"issue":"9894","key":"2527_CR8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","volume":"382","author":"N Bhala","year":"2013","unstructured":"Coxib, traditional NTC, Bhala N, Emberson J, Merhi A, Abramson S, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769\u201379.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"2527_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2165\/00003495-199300461-00063","volume":"46","author":"JL Carson","year":"1993","unstructured":"Carson JL, Willett LR. Toxicity of nonsteroidal anti-inflammatory drugs. An overview of the epidemiological evidence. Drugs. 1993;46(Suppl 1):243\u20138.","journal-title":"Drugs."},{"issue":"4","key":"2527_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1533-2500.2008.00204.x","volume":"8","author":"J Pergolizzi","year":"2008","unstructured":"Pergolizzi J, B\u00f6ger RH, Budd K, Dahan A, Erdine S, Hans G, et al. Opioids and the Management of Chronic Severe Pain in the elderly: consensus statement of an international expert panel with focus on the six clinically Most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Practice. 2008;8(4):287\u2013313.","journal-title":"Pain Practice"},{"issue":"3","key":"2527_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","volume":"22","author":"TE McAlindon","year":"2014","unstructured":"McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil. 2014;22(3):363\u201388.","journal-title":"Osteoarthr Cartil"},{"issue":"7","key":"2527_CR12","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.joca.2015.02.163","volume":"23","author":"C Fingleton","year":"2015","unstructured":"Fingleton C, Smart K, Moloney N, Fullen BM, Doody C. Pain sensitization in people with knee osteoarthritis: a systematic review and meta-analysis. Osteoarthr Cartil. 2015;23(7):1043\u201356.","journal-title":"Osteoarthr Cartil"},{"issue":"3","key":"2527_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.pain.2010.04.003","volume":"149","author":"L Arendt-Nielsen","year":"2010","unstructured":"Arendt-Nielsen L, Nie H, Laursen MB, Laursen BS, Madeleine P, Simonsen OH, et al. Sensitization in patients with painful knee osteoarthritis. Pain. 2010;149(3):573\u201381.","journal-title":"Pain."},{"issue":"3","key":"2527_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.neuron.2007.07.012","volume":"55","author":"I Tracey","year":"2007","unstructured":"Tracey I, Mantyh PW. The cerebral signature for pain perception and its modulation. Neuron. 2007;55(3):377\u201391.","journal-title":"Neuron."},{"key":"2527_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev.ne.14.030191.001251","volume":"14","author":"HL Fields","year":"1991","unstructured":"Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci. 1991;14:219\u201345.","journal-title":"Annu Rev Neurosci"},{"issue":"12","key":"2527_CR16","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.2174\/1381612053764805","volume":"11","author":"FP Bymaster","year":"2005","unstructured":"Bymaster FP, Lee TC, Knadler MP, Detke MJ, Iyengar S. The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression. Curr Pharm Des. 2005;11(12):1475\u201393.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"2527_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1533-2500.2010.00401.x","volume":"11","author":"AS Chappell","year":"2011","unstructured":"Chappell AS, Desaiah D, Liu-Seifert H, Zhang S, Skljarevski V, Belenkov Y, et al. A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee. Pain Pract. 2011;11(1):33\u201341.","journal-title":"Pain Pract"},{"issue":"3","key":"2527_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.pain.2009.06.024","volume":"146","author":"AS Chappell","year":"2009","unstructured":"Chappell AS, Ossanna MJ, Liu-Seifert H, Iyengar S, Skljarevski V, Li LC, et al. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain. 2009;146(3):253\u201360.","journal-title":"Pain."},{"issue":"12","key":"2527_CR19","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.jpain.2010.03.002","volume":"11","author":"V Skljarevski","year":"2010","unstructured":"Skljarevski V, Zhang S, Desaiah D, Alaka KJ, Palacios S, Miazgowski T, et al. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial. J Pain. 2010;11(12):1282\u201390.","journal-title":"J Pain"},{"issue":"13","key":"2527_CR20","doi-asserted-by":"publisher","first-page":"E578","DOI":"10.1097\/BRS.0b013e3181d3cef6","volume":"35","author":"V Skljarevski","year":"2010","unstructured":"Skljarevski V, Desaiah D, Liu-Seifert H, Zhang Q, Chappell AS, Detke MJ, et al. Efficacy and safety of duloxetine in patients with chronic low back pain. Spine (Phila Pa 1976). 2010;35(13):E578\u201385.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"9","key":"2527_CR21","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/j.1468-1331.2009.02648.x","volume":"16","author":"V Skljarevski","year":"2009","unstructured":"Skljarevski V, Ossanna M, Liu-Seifert H, Zhang Q, Chappell A, Iyengar S, et al. A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. Eur J Neurol. 2009;16(9):1041\u20138.","journal-title":"Eur J Neurol"},{"issue":"3","key":"2527_CR22","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.pain.2008.02.024","volume":"136","author":"IJ Russell","year":"2008","unstructured":"Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain. 2008;136(3):432\u201344.","journal-title":"Pain."},{"key":"2527_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/IJGM.S3979","volume":"1","author":"AS Chappell","year":"2008","unstructured":"Chappell AS, Bradley LA, Wiltse C, Detke MJ, D'Souza DN, Spaeth M. A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia. Int J Gen Med. 2008;1:91\u2013102.","journal-title":"Int J Gen Med"},{"issue":"1\u20133","key":"2527_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.pain.2005.06.031","volume":"119","author":"LM Arnold","year":"2005","unstructured":"Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005;119(1\u20133):5\u201315.","journal-title":"Pain."},{"issue":"9","key":"2527_CR25","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1002\/art.20485","volume":"50","author":"LM Arnold","year":"2004","unstructured":"Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheumatism. 2004;50(9):2974\u201384.","journal-title":"Arthritis Rheumatism"},{"issue":"8","key":"2527_CR26","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1212\/01.wnl.0000240225.04000.1a","volume":"67","author":"JF Wernicke","year":"2006","unstructured":"Wernicke JF, Pritchett YL, D'Souza DN, Waninger A, Tran P, Iyengar S, et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology. 2006;67(8):1411\u201320.","journal-title":"Neurology."},{"issue":"5","key":"2527_CR27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1526-4637.2005.00061.x","volume":"6","author":"J Raskin","year":"2005","unstructured":"Raskin J, Pritchett YL, Wang F, D'Souza DN, Waninger AL, Iyengar S, et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med. 2005;6(5):346\u201356.","journal-title":"Pain Med"},{"issue":"1\u20132","key":"2527_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","volume":"116","author":"DJ Goldstein","year":"2005","unstructured":"Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005;116(1\u20132):109\u201318.","journal-title":"Pain."},{"issue":"6","key":"2527_CR29","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.joca.2016.12.025","volume":"25","author":"G Wang","year":"2017","unstructured":"Wang G, Bi L, Li X, Li Z, Zhao D, Chen J, et al. Efficacy and safety of duloxetine in Chinese patients with chronic pain due to osteoarthritis: a randomized, double-blind, placebo-controlled study. Osteoarthr Cartil. 2017;25(6):832\u20138.","journal-title":"Osteoarthr Cartil"},{"key":"2527_CR30","unstructured":"Wang G, Yue L, Wang Y, Due\u00f1as H, Skljarevski V. Maintenance of effect and long-term safety of duloxetine in Chinese patients with pain due to osteoarthritis, Poster number APL-16-0535; Presented 18th Asia Pacific League of Associations for Rheumatology Congress (APLAR 2016). Shanghai; 2016.\u00a0\n                    http:\/\/www.aplar2016.com\/wp-content\/uploads\/2016\/09\/APLAR-2016-Poster-Abstracts.pdf\n                    \n                  .\u00a0Accessed 10 Apr 2019."},{"issue":"2","key":"2527_CR31","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singap. 1994;23(2):129\u201338.","journal-title":"Ann Acad Med Singap"},{"issue":"5","key":"2527_CR32","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1526-4637.2010.00836.x","volume":"11","author":"V Skljarevski","year":"2010","unstructured":"Skljarevski V, Zhang S, Chappell AS, Walker DJ, Murray I, Backonja M. Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study. Pain Med. 2010;11(5):648\u201357.","journal-title":"Pain Med"},{"issue":"7","key":"2527_CR33","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/dmrr.1000","volume":"25","author":"V Skljarevski","year":"2009","unstructured":"Skljarevski V, Desaiah D, Zhang Q, Chappell AS, Detke MJ, Gross JL, et al. Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain. Diabetes Metab Res Rev. 2009;25(7):623\u201331.","journal-title":"Diabetes Metab Res Rev"},{"issue":"8","key":"2527_CR34","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jpain.2014.04.008","volume":"15","author":"S Yu","year":"2014","unstructured":"Yu S, Shen W, Yu L, Hou Y, Han J, Richards HM. Safety and efficacy of once-daily hydromorphone extended-release versus twice-daily oxycodone hydrochloride controlled-release in Chinese patients with Cancer pain: a phase 3, randomized, double-blind, multicenter study. J Pain. 2014;15(8):835\u201344.","journal-title":"J Pain"},{"issue":"6","key":"2527_CR35","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.semarthrit.2008.11.001","volume":"39","author":"PJ Mease","year":"2010","unstructured":"Mease PJ, Russell IJ, Kajdasz DK, Wiltse CG, Detke MJ, Wohlreich MM, et al. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. Semin Arthritis Rheum. 2010;39(6):454\u201364.","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"2527_CR36","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2165\/11319200-000000000-00000","volume":"33","author":"S Brunton","year":"2010","unstructured":"Brunton S, Wang F, Edwards SB, Crucitti AS, Ossanna MJ, Walker DJ, et al. Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies. Drug Saf. 2010;33(5):393\u2013407.","journal-title":"Drug Saf"},{"issue":"3","key":"2527_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1517\/17425255.4.3.281","volume":"4","author":"RS McIntyre","year":"2008","unstructured":"McIntyre RS, Panjwani ZD, Nguyen HT, Woldeyohannes HO, Alsuwaidan M, Soczynska JK, et al. The hepatic safety profile of duloxetine: a review. Expert Opin Drug Metab Toxicol. 2008;4(3):281\u20135.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"2527_CR38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2165\/00002018-200730050-00007","volume":"30","author":"J Wernicke","year":"2007","unstructured":"Wernicke J, Lledo A, Raskin J, Kajdasz DK, Wang F. An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies. Drug Saf. 2007;30(5):437\u201355.","journal-title":"Drug Saf"},{"issue":"1","key":"2527_CR39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jagp.2013.01.019","volume":"22","author":"M Robinson","year":"2014","unstructured":"Robinson M, Oakes TM, Raskin J, Liu P, Shoemaker S, Nelson JC. Acute and long-term treatment of late-life major depressive disorder: duloxetine versus placebo. Am J Geriatr Psychiatry. 2014;22(1):34\u201345.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"2527_CR40","first-page":"1","volume":"15","author":"JC Nelson","year":"2013","unstructured":"Nelson JC, Oakes TM, Liu P, Ahl J, Bangs ME, Raskin J, et al. Assessment of falls in older patients treated with duloxetine: a secondary analysis of a 24-week randomized, placebo-controlled trial. Prim Care Companion CNS Disord. 2013;15(1):1\u201313.","journal-title":"Prim Care Companion CNS Disord"},{"key":"2527_CR41","unstructured":"Cymbalta\u00ae [package insert]. Indianapolis, IN: Eli Lilly & Co; 2015. \n                    http:\/\/pi.lilly.com\/us\/cymbalta-pi.pdf\n                    \n                  . Accessed 12 July 2016."}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-019-2527-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-019-2527-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-019-2527-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T23:05:20Z","timestamp":1587423920000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-019-2527-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,22]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2527"],"URL":"https:\/\/doi.org\/10.1186\/s12891-019-2527-y","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,22]]},"assertion":[{"value":"10 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by ethics review boards (ERB) covering each site, including: ERB of China-Japan Friendship Hospital; Ethics Committee of Guanghua Hospital; ERB of the Third Xiangya Hospital of Central South University; ERB of Anhui Provincial Hospital; Shanghai Changhai Hospital Ethics Committee; ERB of Jilin University China-Japan Union Hospital; Clinical Medical Ethics Committee of the First Affiliated Hospital of Bengbu Medical College; ERB of the Second Xiangya Hospital of Central South University; ERB of the First Affiliated Hospital of Anhui Medical University; ERB of Tianjin Medical University General Hospital; ERB of West China Hospital of Sichuan University; ERB of the General Hospital of Shenyang Military Region; ERB of the First Affiliated Hospital of Jinan University; ERB of Nanfang Hospital; ERB of Pingxiang People\u2019s Hospital; and ERB of Zhuzhou Central Hospital.Written informed consent was obtained from all patients before participation in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GW, LB, XL, ZL, DZ, JC, and DH have no conflicts of interest to report. HD, LY, CW, TW, and VS are or were employees and minor shareholders of Eli Lilly and Company.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"174"}}